XML 126 R67.htm IDEA: XBRL DOCUMENT v3.20.4
Related Party Transactions - Additional Information (Details)
1 Months Ended 12 Months Ended
Mar. 31, 2020
USD ($)
shares
Oct. 31, 2019
USD ($)
Research
Dec. 31, 2020
USD ($)
Dec. 31, 2019
USD ($)
Jun. 05, 2020
USD ($)
Dec. 19, 2019
USD ($)
Novartis | Novartis Agreement            
Related Party Transaction [Line Items]            
Payment to related party   $ 69,600,000        
Committed to provide equity financing   $ 30,000,000        
Percentage of outstanding equity on fully diluted basis     6.10% 7.40%    
Maximum | Novartis | Novartis Agreement            
Related Party Transaction [Line Items]            
Number of Integrin research targets | Research   3        
IPO | Novartis | Novartis Agreement            
Related Party Transaction [Line Items]            
Committed to provide equity financing   $ 10,000,000     $ 10,000,000  
Series C Redeemable Convertible Preferred Stock | Novartis | Novartis Agreement            
Related Party Transaction [Line Items]            
Committed to provide equity financing   $ 20,000,000       $ 20,000,000
Third Rock Ventures | Non-employee Director | Stock Options            
Related Party Transaction [Line Items]            
Option granted | shares 26,573          
Grant date fair value of stock option $ 100,000          
Vesting rights     The common shares subject to these options vest 1/12th on the last day of each calendar quarter over a three-year period and commenced vesting upon our IPO.      
Vesting period     3 years      
UCSF Foundation            
Related Party Transaction [Line Items]            
Payment to related party     $ 700,000 $ 400,000    
Scientific Founders            
Related Party Transaction [Line Items]            
Payment to related party     200,000 200,000    
General and Administrative Expenses | Third Rock Ventures            
Related Party Transaction [Line Items]            
Consulting service expenses     $ 0 $ 36,000